EWM
FLGT icon

Edge Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Edge Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$8K – 510
2020
Q2 		$8K Hold
500
– – ﹤0.01% 489
2020
Q1 		$6K Hold
500
– – ﹤0.01% 448
2019
Q4 		$6K Buy
+500
New +$5.94K ﹤0.01% 469

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edge Wealth Management's FLGT Position: Q3 2020 in Review

Edge Wealth Management sold out of Fulgent Genetics (FLGT) in Q3 2020, closing a stake of 500 shares — an estimated $8K sold.

Edge Wealth Management first reported a position in FLGT in Q4 2019 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 126 funds tracked by Wall St. Rank hold FLGT as of Q3 2020.

  • Edge Wealth Management reported no remaining Fulgent Genetics position as of Q3 2020 after selling out during the quarter.
  • Edge Wealth Management sold 500 Fulgent Genetics shares in Q3 2020, an estimated $8K.
  • Edge Wealth Management first reported a position in Fulgent Genetics in Q4 2019 and held it in 3 quarters.
  • Edge Wealth Management's Fulgent Genetics position peaked at $8K in Q2 2020.
  • 126 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.